Providing health reports on an individual’s specific diseases and conditions, carrier status, health risks and drug responses are medical device uses, requiring either premarket approval or 510(k) clearance, FDA tells the Personal Genome Service testing provider 23andMe Inc. in a Nov. 22 warning letter
.